Injective (INJ) is trading at $7.28 on Binance spot as of November 1, 2026, posting a 2.94% intraday gain while remaining below every near-term moving average. Stochastic readings have pressed into...

Market analysis includes conditional scenarios, not assured price outcomes or investment advice. Check the data, assumptions and dates cited.

INJ's 2.94% intraday bounce to $7.28 — within a 24-hour range of $7.05 to $7.55 on Binance spot — has not been enough to reclaim any meaningful average. The 7-day SMA sits at $7.60, the 50-day SMA at $7.60, the EMA 12 at $7.68, and the EMA 26 at $7.74; all four cluster tightly just above the current price, forming a compressed overhead layer. The 20-day SMA at $8.05 adds further resistance above that. The lone structural positive is the 200-day SMA at $5.53, which sits well below price and reflects how far INJ has traveled off its longer-run lows. In the near term, however, the price structure is bearish: every short-term average is acting as resistance rather than support.

57, placing INJ in the neutral zone — neither overbought nor deeply oversold on that measure. 06 are both deep in oversold territory, a condition that can precede short-term mean reversion but carries no timing guarantee on its own. 0000. That flat histogram means momentum is neither accelerating to the downside nor recovering — it is stalled. Until the histogram turns positive, the MACD offers no bullish confirmation to pair with the Stochastic signal.

Source link